Solid-phase peptide synthesis (SPPS) is a method of chemical synthesis in which a peptide is assembled step by step while attached to an insoluble support, usually a polymer resin. Successive protected amino acids are joined through peptide bonds, and excess reagents and soluble by-products are removed by washing rather than by isolating each intermediate. This arrangement makes repetitive synthesis practical and readily automated. SPPS is widely used to produce research peptides, pharmaceutical ingredients, and synthetic fragments for constructing larger proteins.
Principle and historical development
The central innovation of SPPS is the temporary immobilization of the growing peptide. In conventional solution-phase synthesis, intermediates often require extraction, crystallization, or chromatographic purification before the next reaction. In SPPS, the intermediate remains attached to a solid support throughout most of the synthesis, allowing soluble material to be drained or filtered away.
R. Bruce Merrifield introduced the method in a landmark publication in 1963. Early implementations used cross-linked polystyrene supports and acid-labile protecting groups. The method established a general framework for automated peptide assembly and helped stimulate the broader development of solid-phase organic synthesis. Merrifield received the 1984 Nobel Prize in Chemistry for his development of methodology for chemical synthesis on a solid matrix.
The support simplifies handling, but it does not eliminate the need for highly selective reactions. Impurities produced by incomplete or incorrect reactions can remain attached to the resin alongside the desired chain and accumulate during subsequent cycles.
Direction of chain assembly
In conventional SPPS, the first amino acid is attached through its carboxyl group to a linker on the resin. This residue becomes the peptide’s C-terminal residue. Its amino group is initially protected.
After removal of the amino-protecting group, the carboxyl group of the next protected amino acid is activated and coupled to the exposed amino group of the resin-bound residue. Repetition extends the chain from the C-terminus toward the N-terminus.
This direction is opposite to biological translation, in which the ribosome assembles proteins from the N-terminus toward the C-terminus. Specialized chemical strategies can use other assembly directions, but C-to-N growth is the standard SPPS approach.
The synthesis cycle
A typical cycle contains four main operations:
- Deprotection: removal of the temporary protecting group from the terminal amino group.
- Washing: removal of deprotection reagents and soluble products.
- Coupling: reaction of the exposed amino group with an activated, amino-protected amino acid.
- Further washing: removal of excess amino acid, coupling reagents, and by-products.
An optional capping step blocks amino groups that failed to react. Capping prevents these chains from continuing to grow into deletion-sequence impurities, but converts them into terminated products instead.
After the desired sequence has been assembled, the peptide is cleaved from the support. Side-chain protecting groups are removed either during the same operation or in separate steps, depending on the protecting-group and linker system.
Resins, linkers, and solvents
Solid supports
Common supports include cross-linked polystyrene, polyethylene glycol–modified polystyrene, and polyethylene glycol–based resins. Their suitability depends on chemical stability, swelling, mechanical properties, and compatibility with the intended solvents.
Although called “solid-phase” synthesis, many reactions occur within solvent-swollen polymer beads rather than only on their external surfaces. Reagents must enter the polymer network and reach the growing chains. Consequently, diffusion, swelling, and chain accessibility influence reaction efficiency.
Resin loading describes the amount of reactive functionality per unit mass of support. Higher loading can increase nominal productivity, but close packing of peptide chains may promote association and reduce access to reactive sites. Lower loading can improve difficult syntheses at the cost of requiring more resin.
Linkers
A linker connects the peptide to the support and determines both the conditions needed for release and, often, the identity of the peptide’s C-terminal functional group.
For example:
- Wang-type linkers are commonly used to obtain peptides with a C-terminal carboxylic acid.
- Rink amide linkers are commonly used to obtain C-terminal peptide amides.
- 2-Chlorotrityl linkers can allow release under relatively mild acidic conditions, including preparation of protected peptide fragments.
Linker choice is therefore part of the overall synthetic design rather than merely a means of attachment.
Solvents
Solvents must swell the resin, dissolve reagents, and support coupling and deprotection. Dimethylformamide is widely used, while other polar organic solvents and solvent mixtures are selected for particular resin systems and processes.
Solvent suitability cannot be judged solely by reagent solubility. A solvent that dissolves all reagents but poorly swells the support may still give inefficient synthesis.
Protecting-group strategies
Amino acids contain an amino group and a carboxyl group, and some also possess reactive side chains. Without selective protection, coupling can produce branching, cyclization, or other unwanted products.
A protecting group temporarily suppresses the reactivity of a functional group. SPPS requires a system in which the terminal amino-protecting group can be removed repeatedly without prematurely releasing the peptide or removing side-chain protection.
Fmoc chemistry
The 9-fluorenylmethoxycarbonyl, or Fmoc, group is removed under basic conditions, commonly using piperidine-containing solutions. Side-chain protection and resin attachment are generally designed to tolerate these repeated basic treatments and to be removed under acidic conditions at the end.
This is often called the Fmoc/tBu strategy, because tert-butyl-based groups are widely used for side-chain protection. Final cleavage commonly uses trifluoroacetic acid with additives that limit unwanted reactions involving reactive cleavage products.
Fmoc chemistry is widely adopted because it is compatible with many modified amino acids and avoids the routine use of hydrogen fluoride associated with traditional Boc/benzyl synthesis.
Boc chemistry
The tert-butoxycarbonyl, or Boc, group is removed by acid, commonly trifluoroacetic acid. In traditional Boc/benzyl chemistry, side-chain protecting groups and resin linkages tolerate these repeated treatments but require stronger conditions for final removal.
Traditional final cleavage often uses hydrogen fluoride, which requires specialized equipment and stringent hazard controls. Boc chemistry nevertheless remains useful for particular sequences and synthetic strategies.
Orthogonal protection
Orthogonal protection uses protecting groups that can be removed selectively under distinct conditions. It permits operations such as exposing one side-chain amino group while leaving the peptide backbone terminus and other side chains protected.
Such selectivity supports peptide branching, cyclization, site-specific labeling, and controlled formation of disulfide bonds.
Coupling chemistry and stereochemical control
Peptide-bond formation requires activation of the incoming amino acid’s carboxyl group. Widely used systems include carbodiimide-based reagents and uronium- or phosphonium-based coupling reagents, often combined with additives that improve coupling efficiency or reduce side reactions.
The choice of activation system affects reaction rate, reagent consumption, by-product formation, and preservation of stereochemistry. Activation can promote epimerization at an amino acid’s alpha carbon, especially for susceptible residues or under unfavorable conditions. This may introduce a stereochemical impurity even when the peptide has the correct mass and amino-acid sequence.
Preserving the intended chirality is essential because changes in residue configuration can alter structure, binding, and biological activity.
Automation and process monitoring
Automated peptide synthesizers control reagent delivery, mixing, reaction times, washing, and drainage. Instruments may operate batchwise or use flow-based processing. Some systems apply elevated temperatures or microwave heating to accelerate reactions and improve difficult couplings.
Automation makes repeated operations reproducible but does not guarantee that every reaction reaches completion. Monitoring methods include:
- Color tests for residual free amino groups, such as the Kaiser test.
- Measurement of Fmoc-derived deprotection products to assess removal of the protecting group.
- Small-scale cleavage followed by analytical chromatography and mass spectrometry.
- Instrumental tracking of pressure, flow, temperature, and reagent delivery.
These measurements provide different information. A negative free-amine test, for example, does not establish that the entire attached population has the intended sequence.
Purification and characterization
Cleavage produces a crude mixture that may contain the desired peptide, deletion and truncation products, chemically modified sequences, residual protecting-group products, and other impurities.
Purification commonly uses high-performance liquid chromatography, particularly reversed-phase methods. Mass spectrometry establishes molecular mass and can provide sequence information through fragmentation. Other techniques, including nuclear magnetic resonance, may be needed to establish structural details.
Mass alone is insufficient to demonstrate full identity or purity: some sequence isomers and stereochemical impurities have identical molecular masses. Likewise, a single chromatographic peak under one set of conditions does not exclude all possible impurities.
For peptides with disulfide bonds or complex conformational requirements, purification may be followed by controlled oxidation and folding.
Applications and extensions
SPPS provides direct control over sequence and allows incorporation of building blocks that are difficult to introduce through biological expression. Applications include:
- Peptides used to study enzymes, receptors, and molecular interactions.
- Defined antigens and epitopes for immunological research.
- Peptide pharmaceutical ingredients and related analytical standards.
- Fluorescently labeled, isotope-labeled, or otherwise modified peptides.
- Peptides containing D-amino acids, non-proteinogenic amino acids, or backbone modifications.
- Cyclic peptides, branched structures, and peptide libraries.
For larger targets, separately synthesized fragments can be joined by native chemical ligation or other ligation methods. This reduces the burden of producing an entire long sequence through one uninterrupted series of coupling reactions. Related semisynthetic approaches combine chemically synthesized fragments with recombinantly produced protein segments.
Limitations and environmental considerations
Accumulation of incomplete reactions
Small inefficiencies compound as the number of synthetic operations increases. If each of coupling steps has the same efficiency , a simplified estimate of the fraction of chains undergoing all intended couplings is
At , 100 coupling steps give approximately . At , the corresponding value is approximately . These figures illustrate cumulative losses, not isolated product yields: they exclude deprotection failures, side reactions, cleavage losses, and purification losses.
Sequence-dependent difficulties
Longer chains can aggregate within the resin, restricting reagent access. Backbone hydrogen bonding and hydrophobic association can make certain sequences difficult even when they are relatively short.
Other problems include aspartimide formation, diketopiperazine formation, oxidation, incomplete side-chain deprotection, and unwanted reactions during cleavage. Their significance depends on sequence, resin, reagents, and reaction conditions. There is therefore no universal maximum peptide length for SPPS.
Scale and resource use
SPPS often consumes substantial quantities of solvent and excess reagents. Washing, cleavage, and preparative purification can dominate material use, while the resin is commonly discarded after synthesis. Some widely used solvents and coupling reagents also present occupational or environmental hazards.
Process development addresses these constraints through improved reaction efficiency, reduced wash volumes, alternative solvents, optimized reagent excesses, and hybrid solid- and solution-phase routes. A change that reduces solvent consumption does not necessarily reduce total environmental impact if it increases hazardous reagent use or makes purification more demanding.